According to our (Global Info Research) latest study, the global Nystatin API market size was valued at US$ 39.20 million in 2025 and is forecast to a readjusted size of US$ 49.47 million by 2032 with a CAGR of 3.4% during review period.
In 2025, global Nystatin API production reached approximately 128 tons, with an average global market price of around US$298 per kilogram. Nystatin API (Active Pharmaceutical Ingredient) is the raw material of a polyene - type antifungal drug. It is extracted from the culture broth of Streptomyces noursei and its main component is nystatin. It is a complex compound that belongs to the macrolide antibiotics family and has a conjugated polyene structure.
The global Nystatin API market is characterized by steady, clinically driven demand for topical and oral antifungal formulations, alongside structural differentiation between small-scale reagent supply and larger pharmaceutical API supply. Production predominantly relies on traditional fermentation, with technical differentiation focused on impurity profiles and potency assays; regulatory scrutiny of complex, multi-component APIs has increased the compliance and documentation burden. Trends favor formulation-readiness (micronization), improved process consistency and downstream formulation innovation that can reduce costs and broaden application. Demand-side opportunities arise from consolidation among generic producers, improved access in emerging markets, and potential expansion into veterinary and combination topical products. Key barriers include the intrinsic complexity of fermentation-based manufacture, difficulty controlling related substances and stability, the high costs of demonstrating batch-to-batch consistency for registration, and supply risks from geographic concentration of production. Firms that invest in scalable fermentation controls, advanced impurity analytics, robust stability packages, GMP alignment and supply-chain diversification will be best placed to mitigate risks and capture incremental demand.
This report is a detailed and comprehensive analysis for global Nystatin API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Nystatin API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Nystatin API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Nystatin API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
Global Nystatin API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nystatin API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nystatin API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antibiotice, Centrient Pharmaceuticals, Duchefa Farma, VUAB Pharma, Hubei Hengshuo Chemical, Concord Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Nystatin API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Nystatin Non-micronized
Nystatin Micronized
Nystatin Compacted
Market segment by Particle Size
Particle Size <45μm
Particle Size <10μm
Market segment by Application
External Preparations
Oral Preparations
Major players covered
Antibiotice
Centrient Pharmaceuticals
Duchefa Farma
VUAB Pharma
Hubei Hengshuo Chemical
Concord Biotech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nystatin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Nystatin API, with price, sales quantity, revenue, and global market share of Nystatin API from 2021 to 2026.
Chapter 3, the Nystatin API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nystatin API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Nystatin API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Nystatin API.
Chapter 14 and 15, to describe Nystatin API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Nystatin API. Industry analysis & Market Report on Nystatin API is a syndicated market report, published as Global Nystatin API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Nystatin API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.